G
Gloria Bachmann
Researcher at Rutgers University
Publications - 248
Citations - 10469
Gloria Bachmann is an academic researcher from Rutgers University. The author has contributed to research in topics: Population & Vulvodynia. The author has an hindex of 50, co-authored 231 publications receiving 9654 citations. Previous affiliations of Gloria Bachmann include Robert Wood Johnson University Hospital & University of Alabama at Birmingham.
Papers
More filters
Journal ArticleDOI
The combined effects of physical, sexual, and emotional abuse during childhood: long-term health consequences for women
TL;DR: The greater the number of childhood abuses, the poorer one's adult health and the more likely one was to have experienced abuse as an adult, physical health appears to be adversely affected in women abused as children.
Journal ArticleDOI
Female androgen insufficiency: the princeton consensus statement on definition, classification, and assessment
Gloria Bachmann,John Bancroft,Glenn D. Braunstein,Henry G. Burger,Susan R. Davis,Lorraine Dennerstein,Irwin Goldstein,André T. Guay,Sandra R. Leiblum,Rogerio A. Lobo,Morris Notelovitz,Raymond C. Rosen,Philip M. Sarrel,Barbara B. Sherwin,James A. Simon,Evan R. Simpson,Jan L. Shifren,Richard F. Spark,Abdul Traish +18 more
TL;DR: A new definition of androgen insufficiency in women has been proposed along with consensus-based guidelines for clinical assessment and diagnosis and a simplified management algorithm for women with low androgen in the presence of clinical symptoms and normal estrogen status has also been proposed.
Journal ArticleDOI
Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.
Wulf H. Utian,David F. Archer,Gloria Bachmann,Gallagher C,Grodstein Fn,Heiman,Victor W. Henderson,Howard N. Hodis,Richard H. Karas,Roger A. Lobo,JoAnn E. Manson,Robert L. Reid,Peter Schmidt,Cynthia A. Stuenkel +13 more
TL;DR: Current evidence supports a consensus regarding the role of HT in postmenopausal women, when potential therapeutic benefits and risks around the time of menopause are considered, and a recommended list of areas for future HT research.
Journal ArticleDOI
Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee.
TL;DR: Estrogen is efficacious in the treatment of urogenital atrophy and low-dose vaginal estradiol preparations are as effective as systemic estrogen therapy in the Treatment of Urogenitalatrophy in postmenopausal women.
Journal ArticleDOI
Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate
TL;DR: Lower doses of CEE plus MPA relieve vasomotor symptoms and vaginal atrophy as effectively as commonly prescribed doses.